Cargando…
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome
INTRODUCTION: The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic acid sequences. Properties of the host response are not measured but are key in determining outcome. Although metabolic profiles are well suited to capture host state, most metabolomics studies ar...
Autores principales: | Roberts, Ivayla, Wright Muelas, Marina, Taylor, Joseph M., Davison, Andrew S., Xu, Yun, Grixti, Justine M., Gotts, Nigel, Sorokin, Anatolii, Goodacre, Royston, Kell, Douglas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686810/ https://www.ncbi.nlm.nih.gov/pubmed/34928464 http://dx.doi.org/10.1007/s11306-021-01859-3 |
Ejemplares similares
-
An untargeted metabolomics strategy to measure differences in metabolite uptake and excretion by mammalian cell lines
por: Wright Muelas, Marina, et al.
Publicado: (2020) -
Quantitative LC–MS study of compounds found predictive of COVID-19 severity and outcome
por: Roberts, Ivayla, et al.
Publicado: (2023) -
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery()
por: Kell, Douglas B., et al.
Publicado: (2014) -
Corrigendum to “Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery” [Drug Discov. Today 19 (2014), 171–182()
por: Kell, Douglas B, et al.
Publicado: (2014) -
MassGenie: A Transformer-Based Deep Learning Method for Identifying Small Molecules from Their Mass Spectra
por: Shrivastava, Aditya Divyakant, et al.
Publicado: (2021)